🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next week, our COO Daniel Rooke will be taking part in the "Investment Reverse Pitch" at The UK MedTech Innovation Assembly '23 where you'll get to grill him on how we can support the #MedTech ecosystem. 📅 02 November ⌚ 12:15-13:00 Sign up here: rb.gy/s3859

Next month, our Investment Director, Michael Salako PhD MBA, will visit the University of Bristol to give a talk about our offerings at Start Codon & to learn about exciting Health & #LifeScience technologies being developed in Bristol. Learn more here: rb.gy/1a085

Today, our CEO Jason Mellad will be participating in a panel discussion at the Questrom School of Business, Boston University Health & Life Science Conference. 👉Panel: Cultivating an Ecosystem for #Healthcare #Innovation ⌚ 17:00-17:50 BST, 12:00-12:50 EDT Join the discussion here: rb.gy/9ocnh

Save the date! Our Investment Director, Michael Salako PhD MBA will be attending LSX Leaders annual #Investival Showcase taking place in London on 13 Nov. Find out more: bit.ly/47hCOUa

Next week, our #Investment Director Michael Salako PhD MBA, will be attending this year's JefferiesEvents London #Healthcare Conference, taking place 14-16 November. Learn more here: bit.ly/3QGyYOL #JefferiesHealthcare

Our COO, Daniel Rooke is speaking at the IE Cambridge Expo today discussing how to navigate the commercial realities of venture building. ⌚ 13:40-14:00 📍 14/11 - Milner Therapeutics Institute Register here: rb.gy/j5z712 #Entrepreneur #Startup

Our CEO, Jason Mellad, chaired a panel talk at @CR_Horizon's #Innovation Summit today on 'Charting the pathways to patient impact: the role of start-ups in oncology innovation', exploring how to avoid pitfalls as an entrepreneur in #cancer research: rb.gy/fdr932

Next week, our COO, Daniel Rooke, will be joining the discussion: "Buy, Borrow or Grow-Your-Own?" at #Genesis23, to explore what drives a board's strategic decisions for growth as a company's R&D pipeline and business develops. Register here: rb.gy/63vnn8

Some great news from Cambridge Ahead this week! Our CEO, Jason Mellad has been appointed as co-Chair, alongside Jacqueline Platt, to the Young Advisory Committee – created by #Cambridge Ahead to give younger workers a voice in shaping the city’s future. Read more: bit.ly/3GlsBud

In a recent article published in Nature Biotechnology, the authors discuss how #AI could be revolutionary in #healthcare systems and the challenges that remain to protect patient privacy and ensure correct use of clinical data. Read the full article here: rb.gy/0cuvkh

Last month, Norwich Research Park Park hosted the final for an Innovation Hothouse competition for start-up companies. Our CEO, Jason Mellad, joined a panel session at the event to discuss how #startups should prepare for and secure investment: rb.gy/f7me2e

The #menopause is back in the news this week with the approval of a drug for hot flushes: rb.gy/jd0dvs Our portfolio company, Adora, provides personalised support to women going through menopause. Find out how here: adora.health/about-us

Another year almost over and plenty to reflect on... Read more about what the Start Codon team's been up to and what some of our portfolio companies achieved this year in our new blog: rb.gy/uepjva #YearInReview2023 bit.ly/3v8ggr5

🎄 From all of us at Start Codon, we hope you have a wonderful Christmas and a happy New Year!

To celebrate the holiday season, earlier this month the Start Codon team got together for some festive fun! Can you guess what 'scientific' activity we got up to?🧪 Comment your guesses below ahead of the reveal later this week!

To best prepare for what 2024 holds, #startups need to focus on building strong, experienced teams. Join our webinar taking place on Jan 17, to hear predictions & advice for startups from industry experts: rb.gy/y2up4l

"Signs are that the funding environment for 2024 is generally going to be a difficult one." Our investment director, Michael Salako, recently spoke to Scrip about his 2024 predictions for the #funding environment, M&A & #partnering in biopharma: rb.gy/5e4r8d

We are taking a step back from X. Follow our LinkedIn page: rb.gy/48dn2l, and visit our website for the latest updates: rb.gy/tk813e